Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
101.70
-0.30 (-0.29%)
At close: May 24, 2026
Market Cap23.49B -14.1%
Revenue (ttm)14.78B +27.7%
Net Income1.24B +117.1%
EPS5.36 +117.1%
Shares Out 231.00M
PE Ratio18.98
Forward PEn/a
Dividend2.10 (2.06%)
Ex-Dividend DateNov 17, 2025
Volume164,145
Open102.10
Previous Close102.00
Day's Range101.50 - 102.50
52-Week Range96.00 - 147.50
Beta-0.40
Analystsn/a
Price Targetn/a
Earnings DateOct 29, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestin... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,771
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In fiscal year 2025, Beacon Pharmaceuticals's revenue was 12.54 billion, an increase of 17.20% compared to the previous year's 10.70 billion. Earnings were 946.51 million, an increase of 81.67%.

Financial Statements